Ditchcarbon
  • Contact
  1. Organizations
  2. Omeros Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 months ago

Omeros Corporation Sustainability Profile

Company website

Omeros Corporation, a biopharmaceutical company headquartered in the United States, is renowned for its innovative approach to drug development. Founded in 1994, Omeros has made significant strides in the fields of ophthalmology, immunology, and neurology, focusing on the discovery and commercialisation of novel therapeutics. The company’s flagship products, including the FDA-approved Omidria, exemplify its commitment to addressing unmet medical needs with unique formulations that enhance surgical outcomes. Omeros has established a strong market position, bolstered by its proprietary platform technologies and a robust pipeline of drug candidates. With a dedication to advancing patient care, Omeros continues to be a leader in the biopharmaceutical industry, driving forward with a vision of transformative therapies.

DitchCarbon Score

How does Omeros Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Omeros Corporation's score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

28%

Let us know if this data was useful to you

Omeros Corporation's reported carbon emissions

Omeros Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Omeros Corporation may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, Omeros Corporation's future climate commitments will be crucial for aligning with global standards and expectations.

How Carbon Intensive is Omeros Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Omeros Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Omeros Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Omeros Corporation is in US, which has a low grid carbon intensity relative to other regions.

Omeros Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Omeros Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Omeros Corporation's Emissions with Industry Peers

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Bausch Health Cos

CA
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 28 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251204.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy